Low-Salt HIC RNA Purification for Residual Protein Removal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for purifying mRNA from in vitro transcription (IVT) reactions suffer from low purity, high residual protein content, and high costs, particularly when using ambient oligo-dT alone or in combination with reverse-phase HPLC.
Innovation Solution
The use of a flow-through column comprising hydrophobic interaction chromatography (HIC) resin with low-salt conditions, combined with denaturing oligo-dT resin, effectively purifies mRNA by allowing residual protein to bind while preventing mRNA from binding, resulting in high purity and reduced residual protein levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If ambient oligo-dT alone is used for mRNA purification, then the process is simple and cost-effective, but the purity of tailed mRNA is low and residual protein levels are high
Solution Approach 1:
The purification process is divided into two distinct stages: first, flow-through HIC to remove residual proteins from the IVT reaction mixture; second, oligo-dT chromatography to capture and purify the mRNA. This segmentation allows each step to optimize for its specific function, achieving both high purity and protein removal without requiring complex integrated systems
Solution Approach 2:
The patent introduces an intermediary purification step using flow-through HIC resin between the IVT reaction and the final oligo-dT purification. This intermediary step specifically targets and removes residual proteins that would otherwise contaminate the final mRNA product, enabling the oligo-dT step to focus solely on mRNA capture and purification
2Ease of manufacture
If ambient oligo-dT alone is used for mRNA purification, then the process is cost-effective, but residual protein clearance is low
Solution Approach 1:
The patent extracts and removes the harmful residual proteins from the IVT reaction mixture through the flow-through HIC step before proceeding to mRNA purification. By taking out the protein contaminants in an early stage, the subsequent oligo-dT purification works with a cleaner sample, reducing the need for additional protein removal steps and maintaining cost-effectiveness
Solution Approach 2:
The patent converts the potentially harmful residual proteins into a separable component by exploiting their hydrophobic interactions with the HIC resin. The proteins, which would normally be contaminants, are systematically removed through controlled hydrophobic binding, transforming the purification challenge into an efficient separation process
3Manufacturing precision
If reverse-phase HPLC is combined with ambient oligo-dT for mRNA purification, then mRNA purity is improved, but the process becomes cost-prohibitive at large scale
Solution Approach 1:
The patent replaces expensive, scale-limiting reverse-phase HPLC systems with more economical chromatography approaches using standard oligo-dT resin and flow-through HIC resin. These materials can be used at large scales without the prohibitive costs associated with HPLC, effectively providing a disposable, cost-effective purification solution for large-scale mRNA production
Solution Approach 2:
The patent changes the purification parameters by using flow-through mode for HIC instead of traditional batch binding, and by optimizing the sequence of purification steps. These parameter changes enable scalable processing while maintaining high purity, avoiding the scale limitations and high costs of reverse-phase HPLC
4Reliability
If traditional purification methods are used, then the process is established and reliable, but chromatography productivity is low
Solution Approach 1:
The patent implements continuous flow-through purification where the mRNA-containing solution continuously passes through the HIC resin column, allowing proteins to be removed in real-time without batch processing interruptions. This continuous action significantly increases chromatography productivity while maintaining the reliability of established chromatography principles
Solution Approach 2:
The patent performs preliminary protein removal via flow-through HIC before the main mRNA purification step. By preparing the sample in advance by removing proteins, the subsequent oligo-dT purification step can proceed more efficiently with higher productivity, as it doesn't need to deal with protein contaminants that would slow down the process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves a 15.8-fold improvement in chromatography productivity, producing highly purified mRNA with very low residual protein levels, thus reducing costs and increasing efficiency.
Implementation Method 1
hydrophobic interaction chromatography (HIC) resin, wherein the mixture comprising RNA is a low-salt mixture, and/or wherein the HIC resin has high hydrophobicity
Implementation Method 2
denaturing oligo-dT resin (e.g., denaturing oligo-dT, e.g., under low-salt conditions)
Data Source
AI summary
Provided herein, in some embodiments, are methods of purifying low-salt RNA compositions using a flow-through column comprising hydrophobic interaction chromatography (HIC) resin having high hydrophobicity.